Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions von Pradeep, C. -R, Zeisel, A., Köstler, W. J., Lauriola, M., Jacob-Hirsch, J., Haibe-Kains, B., Amariglio, N., Ben-Chetrit, N., Emde, A., Solomonov, I., Neufeld, G., Piccart, M., Sagi, I., Sotiriou, C., Rechavi, G., Domany, E., Desmedt, C., Yarden, Y.

Volltext

Third consensus on medical treatment of metastatic breast cancer von Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., Jassem, J., Köstler, W. J., Krainer, M., Menard, S., Petit, T., Petruzelka, L., Possinger, K., Schmid, P., Stadtmauer, E., Stockler, M., Van Belle, S., Vogel, C., Wilcken, N., Wiltschke, C., Zielinski, C. C., Zwierzina, H.

Volltext

A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis von Lindzen, M, Carvalho, S, Starr, A, Ben-Chetrit, N, Pradeep, C-R, Köstler, W J, Rabinkov, A, Lavi, S, Bacus, S S, Yarden, Y

Volltext

Second consensus on medical treatment of metastatic breast cancer von Beslija, S., Bonneterre, J., Burstein, H., Cocquyt, V., Gnant, M., Goodwin, P., Heinemann, V., Jassem, J., Köstler, W.J., Krainer, M., Menard, S., Petit, T., Petruzelka, L., Possinger, K., Schmid, P., Stadtmauer, E., Stockler, M., Van Belle, S., Vogel, C., Wilcken, N., Wiltschke, C., Zielinski, C.C., Zwierzina, H.

Volltext

Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions von Pradeep, C-R, Zeisel, A, Köstler, W J, Lauriola, M, Jacob-Hirsch, J, Haibe-Kains, B, Amariglio, N, Ben-Chetrit, N, Emde, A, Solomonov, I, Neufeld, G, Piccart, M, Sagi, I, Sotiriou, C, Rechavi, G, Domany, E, Desmedt, C, Yarden, Y

Volltext

Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling von Pradeep, C-R, Köstler, W J, Lauriola, M, Granit, R Z, Zhang, F, Jacob-Hirsch, J, Rechavi, G, Nair, H B, Hennessy, B T, Gonzalez-Angulo, A M, Tekmal, R R, Ben-Porath, I, Mills, G B, Domany, E, Yarden, Y

Volltext

Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab von Bates, M., Sperinde, J., Köstler, W.J., Ali, S.M., Leitzel, K., Fuchs, E.M., Paquet, A., Lie, Y., Sherwood, T., Horvat, R., Singer, C.F., Winslow, J., Weidler, J.M., Huang, W., Lipton, A.

Volltext

The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS) von Ploner, F., Lamm, W., Schur, S., Eisterer, W., Kühr, T., Lindorfer, A., Tinchon, C., Köstler, W. J., Szkandera, J., Brodowicz, T.

Volltext

Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations von Hudelist, G, Wagner, T, Rosner, M, Fink-Retter, A, Gschwantler-Kaulich, D, Czerwenka, K, Kroiss, R, Tea, M, Pischinger, K, Köstler, W J, Attems, J, Mueller, R, Blaukopf, C, Kubista, E, Hengstschläger, M, Singer, C F

Volltext

Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatm... von HUDELIST, G, KÖSTLER, W. J, ATTEMS, J, CZERWENKA, K, MÜLLER, R, MANAVI, M, STEGER, G. G, KUBISTA, E, ZIELINSKI, C. C, SINGER, C. F

Volltext

Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial von Hejna, M, Köstler, W.J, Raderer, M, Steger, G.G, Brodowicz, T, Scheithauer, W, Wiltschke, C, Zielinski, C.C

Volltext

Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment von Kostler, Wolfgang J, Hejna, Michael, Wenzel, Catharina, Zielinski, Christoph C

Volltext

Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: Results of a phase II trial von Köstler, W. J., Brodowicz, T., Attems, Y., Hejna, M., Tomek, S., Amann, G., Fiebiger, W. C. C., Wiltschke, Ch, Krainer, M., Zielinski, Ch. C.

Volltext

Clinical Signs of Neurofibromatosis Impact on the Outcome of Malignant Peripheral Nerve Sheath Tumors von Lamm, W., Schur, S., Köstler, W.J., Funovics, P., Windhager, R., Amann, G., Panotopoulos, J., Pokrajac, B., Brodowicz, T.

Volltext

Reply to Third consensus on medical treatment of metastatic breast cancer von Köstler, W.J., Zielinski, C.C.

Volltext

Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer von Brodowicz, T., Kostler, W.J., Möslinger, R., Tomek, S., Vaclavik, I., Herscovici, V., Wiltschke, C., Steger, G.G., Wein, W., Seifert, M., Kubista, E., Zielinski, C.C.

Volltext

Soluble ICAM-1 in breast cancer: clinical significance and biological implications von KÖSTLER, Wolfgang J, TOMEK, Sandra, BRODOWICZ, Thomas, BUDINSKY, Alexandra C, FLAMM, Maria, HEJNA, Michael, KRAINER, Michael, WILTSCHKE, Christoph, ZIELINSKI, Christoph C

Volltext

Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer von Brodowicz, Thomas, Wolfram, Roswitha M, Köstler, Wolfgang J, Tomek, Sandra, Vaclavik, Ilse, Steger, Günther G, Teleky, Bela, Függer, Reinhard, Jakesz, Raimund, Zielinski, Christoph C

Volltext

Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancer von Hejna, Michael, Köstler, Wolfgang J, Raderer, Markus, Tomek, Sandra, Brodowicz, Thomas, Scheithauer, Werner, Wiltschke, Christoph, Zielinski, Christoph C

Volltext

Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab von Sperinde, J., Ali, S., Leitzel, K., Fuchs, E., Köstler, W. J., Paquet, A., Weidler, J., Huang, W., Bates, M., Lipton, A.

Volltext